CSE: DOSE), ("RDT") announced today that they have signed a Manufacturing Agreement ("the Agreement") with Thrive Cannabis ("Thrive") to produce QuickStrip™ cannabis products for both the Canadian medical and recreational markets. This Agreement represents a continuation of the RDT growth strategy.” data-reactid=”11″>BURLINGTON, ON and BRANTFORD, ON, Aug. 8, 2019 /CNW/ – Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today that they have signed a Manufacturing Agreement (“the Agreement”) with Thrive Cannabis (“Thrive”) to produce QuickStrip™ cannabis products for both the Canadian medical and recreational markets. This Agreement represents a continuation of the RDT growth strategy.
RDT’s proprietary QuickStrip™ technology is a smoke-free, sublingual, fast-dissolving drug delivery system that offers an Anytime, Anywhere™ product for medical and recreational consumers.
“We are demonstrating our ongoing commitment to providing consumers in the Canadian medical and recreational cannabis markets a Smoke-Free Choice™ with a proprietary delivery technology that is Quick, Convenient, Precise and Discreet™,” said Mark Upsdell , CEO of RDT. “RDT will continue to expand our strategic partnerships and further strengthen our unique delivery leadership position within the cannabis sector. This agreement with Thrive proves that QuickStrip™ is a desirable technology and delivery option for Canadian consumers, while simultaneously offering health benefits and improving consumer outcomes,” added Upsdell.
Thrive expects to allocate a significant proportion of its high-quality processed distillate to the production of QuickStrip™, launching under its first brand, GreyBeard and then following with a women-focused QuickStrip™ product. Thrive will also take on new medical and consumer brand production for other Canadian licensed producers.
Todd Masse , Thrive CCO, states “This Agreement enables Thrive to ensure complete coverage and demand fulfillment where gaps may have otherwise existed. All Canadians should have access to the QuickStrip™ delivery technology. The Agreement with RDT will enable Thrive to provide QuickStrip™ product to a wide cannabis consumer base across Canada . QuickStrip™ allows us to offer consumers and patients a No Smoke. No Smell. No Stigma™ product.” Masse continues, “In the coming weeks we will be evaluating white label opportunities with other leading cannabis organizations.”
www.rapid-dose.com” data-reactid=”28″>For more information, visit: www.rapid-dose.com
RapidDoseTherapeutics.linkedin
RapidDoseTherapeutics.twitter
RapidDoseTherapeutics.facebook
QuickStrip.instagram” data-reactid=”29″>Social Media
RapidDoseTherapeutics.linkedin
RapidDoseTherapeutics.twitter
RapidDoseTherapeutics.facebook
QuickStrip.instagram
www.thrivecannabis.ca” data-reactid=”35″>For more information on TerraFarma / Thrive Cannabis, please visit www.thrivecannabis.ca
http://www.prnewswire.com/news-releases/rapid-dose-therapeutics-and-thrive-cannabis-sign-manufacturing-agreement-for-quickstrip-cannabis-products-300898727.html” data-reactid=”59″>View original content to download multimedia:http://www.prnewswire.com/news-releases/rapid-dose-therapeutics-and-thrive-cannabis-sign-manufacturing-agreement-for-quickstrip-cannabis-products-300898727.html
SOURCE Rapid Dose Therapeutics Corp.
http://www.newswire.ca/en/releases/archive/August2019/08/c6678.html” data-reactid=”69″>View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2019/08/c6678.html
Recent Comments